68 related articles for article (PubMed ID: 19924647)
1. The role of cancer stem cells and the side population in epithelial ovarian cancer.
Fong MY; Kakar SS
Histol Histopathol; 2010 Jan; 25(1):113-20. PubMed ID: 19924647
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer.
Pullen RL
Nursing; 2024 Jun; 54(6):17-28. PubMed ID: 38757992
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant.
Hu L; McArthur C; Jaffe RB
Br J Cancer; 2010 Apr; 102(8):1276-83. PubMed ID: 20354527
[TBL] [Abstract][Full Text] [Related]
4. Advancing cancer theranostics through biomimetics: A comprehensive review.
Anitha K; Chenchula S; Surendran V; Shvetank B; Ravula P; Milan R; Chikatipalli R; R P
Heliyon; 2024 Mar; 10(6):e27692. PubMed ID: 38496894
[TBL] [Abstract][Full Text] [Related]
5. New trends in diagnosing and treating ovarian cancer using nanotechnology.
Zhang J; Ding H; Zhang F; Xu Y; Liang W; Huang L
Front Bioeng Biotechnol; 2023; 11():1160985. PubMed ID: 37082219
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway.
Gao Y; Li H; Han Q; Li Y; Wang T; Huang C; Mao Y; Wang X; Zhang Q; Tian J; Irwin DM; Tan H; Guo H
J Cancer; 2020; 11(11):3151-3164. PubMed ID: 32231719
[No Abstract] [Full Text] [Related]
7. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.
Karmakar S; Seshacharyulu P; Lakshmanan I; Vaz AP; Chugh S; Sheinin YM; Mahapatra S; Batra SK; Ponnusamy MP
Oncotarget; 2017 Feb; 8(9):14806-14820. PubMed ID: 28122356
[TBL] [Abstract][Full Text] [Related]
8. Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.
Virant-Klun I; Stimpfel M
Sci Rep; 2016 Oct; 6():34730. PubMed ID: 27703207
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells.
Biava PM; Canaider S; Facchin F; Bianconi E; Ljungberg L; Rotilio D; Burigana F; Ventura C
Curr Pharm Biotechnol; 2015; 16(9):782-92. PubMed ID: 26201607
[TBL] [Abstract][Full Text] [Related]
10. VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients.
Kwon AY; Kim GI; Jeong JY; Song JY; Kwack KB; Lee C; Kang HY; Kim TH; Heo JH; An HJ
Stem Cells Dev; 2015 Jul; 24(13):1521-35. PubMed ID: 25715123
[TBL] [Abstract][Full Text] [Related]
11. OVCAR-3 spheroid-derived cells display distinct metabolic profiles.
Vermeersch KA; Wang L; Mezencev R; McDonald JF; Styczynski MP
PLoS One; 2015; 10(2):e0118262. PubMed ID: 25688563
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.
Pandrangi SL; Raju Bagadi SA; Sinha NK; Kumar M; Dada R; Lakhanpal M; Soni A; Malvia S; Simon S; Chintamani C; Mohil RS; Bhatnagar D; Saxena S
Cancer Cell Int; 2014 Feb; 14(1):14. PubMed ID: 24502646
[TBL] [Abstract][Full Text] [Related]
13. Aiming to immune elimination of ovarian cancer stem cells.
Di J; Duiveman-de Boer T; Figdor CG; Torensma R
World J Stem Cells; 2013 Oct; 5(4):149-62. PubMed ID: 24179603
[TBL] [Abstract][Full Text] [Related]
14. The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.
Di J; Duiveman-de Boer T; Zusterzeel PL; Figdor CG; Massuger LF; Torensma R
Cell Oncol (Dordr); 2013 Oct; 36(5):363-74. PubMed ID: 23928726
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro.
Chung WM; Chang WC; Chen L; Chang YY; Shyr CR; Hung YC; Ma WL
Stem Cell Res Ther; 2013 Jul; 4(4):88. PubMed ID: 23890123
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.
Chen X; Zhang J; Zhang Z; Li H; Cheng W; Liu J
Hum Pathol; 2013 Nov; 44(11):2373-84. PubMed ID: 23850493
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells.
Jiao J; Huang L; Ye F; Shi M; Cheng X; Wang X; Hu D; Xie X; Lu W
Onco Targets Ther; 2013; 6():667-77. PubMed ID: 23836980
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland cancer stem cells.
Adams A; Warner K; Nör JE
Oral Oncol; 2013 Sep; 49(9):845-853. PubMed ID: 23810400
[TBL] [Abstract][Full Text] [Related]
19. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
Skubitz AP; Taras EP; Boylan KL; Waldron NN; Oh S; Panoskaltsis-Mortari A; Vallera DA
Gynecol Oncol; 2013 Sep; 130(3):579-87. PubMed ID: 23721800
[TBL] [Abstract][Full Text] [Related]
20. TRA-1-60
Malecki M; Anderson M; Beauchaine M; Seo S; Tombokan X; Malecki R
J Stem Cell Res Ther; 2012 Nov; 2(5):. PubMed ID: 23293749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
